Amussen Hunsaker & Associates LLC Buys New Position in HealthEquity, Inc. (HQY)

Amussen Hunsaker & Associates LLC bought a new stake in HealthEquity, Inc. (NASDAQ:HQY) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 232,746 shares of the company’s stock, valued at approximately $11,598,000. HealthEquity makes up 12.8% of Amussen Hunsaker & Associates LLC’s portfolio, making the stock its 2nd largest holding. Amussen Hunsaker & Associates LLC owned about 0.39% of HealthEquity as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. BlackRock Inc. lifted its stake in HealthEquity by 4.3% in the 2nd quarter. BlackRock Inc. now owns 5,831,014 shares of the company’s stock valued at $290,559,000 after acquiring an additional 241,061 shares in the last quarter. Vanguard Group Inc. lifted its stake in HealthEquity by 3.0% in the 2nd quarter. Vanguard Group Inc. now owns 4,237,298 shares of the company’s stock valued at $211,145,000 after acquiring an additional 122,061 shares in the last quarter. FMR LLC lifted its stake in HealthEquity by 45.6% in the 2nd quarter. FMR LLC now owns 2,235,150 shares of the company’s stock valued at $111,378,000 after acquiring an additional 699,728 shares in the last quarter. Janus Henderson Group PLC lifted its stake in HealthEquity by 627.9% in the 2nd quarter. Janus Henderson Group PLC now owns 2,113,030 shares of the company’s stock valued at $105,292,000 after acquiring an additional 1,822,732 shares in the last quarter. Finally, State Street Corp lifted its stake in HealthEquity by 10.8% in the 2nd quarter. State Street Corp now owns 1,172,117 shares of the company’s stock valued at $58,411,000 after acquiring an additional 114,294 shares in the last quarter. Hedge funds and other institutional investors own 90.97% of the company’s stock.

In other HealthEquity news, Director Frank Medici sold 316,644 shares of the firm’s stock in a transaction on Monday, October 9th. The stock was sold at an average price of $51.96, for a total value of $16,452,822.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Berkley Capital, Llc sold 1,100 shares of the firm’s stock in a transaction on Monday, October 9th. The stock was sold at an average price of $51.95, for a total value of $57,145.00. The disclosure for this sale can be found here. Insiders sold 712,788 shares of company stock valued at $36,434,549 over the last three months. Company insiders own 29.00% of the company’s stock.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, September 5th. The company reported $0.27 EPS for the quarter, topping the Zacks’ consensus estimate of $0.14 by $0.13. HealthEquity had a return on equity of 13.93% and a net margin of 20.27%. The business had revenue of $56.90 million for the quarter, compared to analyst estimates of $55.66 million. During the same period last year, the company posted $0.16 earnings per share. HealthEquity’s quarterly revenue was up 28.7% compared to the same quarter last year.

Several equities research analysts have commented on HQY shares. Cantor Fitzgerald boosted their target price on HealthEquity from $55.00 to $56.00 and gave the company an “overweight” rating in a research note on Wednesday, July 5th. Zacks Investment Research upgraded HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 target price on the stock in a research note on Wednesday, July 12th. BidaskClub cut HealthEquity from a “buy” rating to a “hold” rating in a research note on Monday, July 24th. TheStreet raised HealthEquity from a “c” rating to a “b” rating in a research report on Monday, July 31st. Finally, Oppenheimer Holdings, Inc. reaffirmed a “buy” rating and set a $61.00 price target on shares of HealthEquity in a research report on Wednesday, September 6th. Two analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $57.17.

TRADEMARK VIOLATION NOTICE: This piece was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of international trademark and copyright law. The correct version of this piece can be accessed at https://sportsperspectives.com/2017/10/13/amussen-hunsaker-associates-llc-buys-new-position-in-healthequity-inc-hqy.html.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply